Webinar with Li Ma, SVP of AliHealth

Webinar with Li Ma, SVP of AliHealth

Regular price
USD $50
Sale price
USD $50
Regular price
Sold out
Unit price
per 

China’s well-funded healthcare technology segment looks set to expand with greater vigour in the wake of Covid-19. The pandemic has led to a spike in demand for online pharmacy and telemedicine services, both expected to make up an online healthcare market worth 200 billion yuan in 2020. Another technology that promises to reduce the strain on medical resources is AI, which is a critical priority in view of the country’s shortfall in medical talent. As a leader in healthtech, Alibaba Health’s wide-ranging business portfolio covers many prominent healthtech categories, from e-commerce to telemedicine and healthcare AI

In our upcoming webinar, SCMP’s business correspondent Eric Ng will chat with Alibaba Health’s SVP Li Ma to understand the latest developments in Alibaba Health’s various business ventures, and what they will mean for the wider China healthcare market. Questions they will discuss include: 

- How has Alibaba Health dealt with the challenges and adjusted the way it serves customers' needs in the wake of the pandemic? 

- Alibaba Health was one of the first pilot enterprises to conduct cross-border pharmaceutical e-commerce business in China. What products from which countries are the most sought after by mainland consumers? 

- Have online consultation services offered by the Alibaba Health Network Hospital been popular? What are the limitations on their scope? 

- What is Alibaba Health’s role in promoting the use of AI technology in healthcare, such as quantitative analysis of electrical activity of the brain, and the use of AI to help doctors conduct quick COVID-19 screening through CT imaging? 


Date And Time
Tuesday, 13th October, 2020
10:00 AM - 11:00 AM Hong Kong Time